Diet-derived phytochemicals: From cancer chemoprevention to cardio-oncological prevention

N. Ferrari, F. Tosetti, S. De Flora, F. Donatelli, I. Sogno, D. M. Noonan, A. Albini

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Cardiovascular diseases and cancer are the leading causes of death in most countries. These diseases share many common risk factors as well as pathogenetic determinants, and their incidence is related to age in an exponential manner. Furthermore, it has become apparent that several treatments used in therapy or even in prevention of cancer can impair the structural and functional integrity of the cardiovascular system, giving rise to an interdisciplinary field: cardiooncology. However, tumors and cardiovascular diseases also share common protective factors: they can be prevented either by avoiding exposure to recognized risk factors, and/or by favoring the intake of protective compounds and by modulating the host defense machinery. These latter approaches are generally known as chemoprevention. A great variety of dietary and pharmacological agents have been shown to be potentially capable of preventing cancer in preclinical models, most of which are of plant origin. Phytochemicals, in particular diet-derived compounds, have therefore been proposed and applied in clinical trials as cancer chemopreventive agents. There is now increasing evidence that some phytochemicals can be also protective for the heart, having the potential to reduce cancer, cardiovascular disease and even anticancer drug-induced cardiotoxicity. We introduce the concept that these compounds induce pre-conditioning, a low level cellular stress that induces strong protective mechanisms conferring resistance to toxins such as cancer chemotherapeutics. Cancer cells and cardiomyocytes have fundamental differences in their metabolism and sensitivity to preconditioning, autophagy and apoptosis, so that dosage of the prevention compounds is important. Here we discuss the mechanisms responsible for the cardiotoxicity of anticancer drugs, the possibility to prevent them and provide examples of diet-derived phytochemicals and other biological substances that could be exploited for protecting the cardiovascular system according to a joint cardio-oncological preventative approach.

Original languageEnglish
Pages (from-to)1909-1924
Number of pages16
JournalCurrent Drug Targets
Volume12
Issue number13
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Chemoprevention
Phytochemicals
Nutrition
Diet
Cardiovascular system
Neoplasms
Cardiovascular Diseases
Cardiovascular System
Metabolism
Pharmaceutical Preparations
Machinery
Tumors
Cells
Apoptosis
Autophagy
Cardiac Myocytes
Cause of Death
Joints
Clinical Trials
Pharmacology

Keywords

  • Autophagy
  • Cancer
  • Cardioncology
  • Cardiotoxicity
  • Cardiovascular diseases
  • Chemoprevention
  • Phytochemicals
  • Preconditioning

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Diet-derived phytochemicals : From cancer chemoprevention to cardio-oncological prevention. / Ferrari, N.; Tosetti, F.; De Flora, S.; Donatelli, F.; Sogno, I.; Noonan, D. M.; Albini, A.

In: Current Drug Targets, Vol. 12, No. 13, 12.2011, p. 1909-1924.

Research output: Contribution to journalArticle

@article{4938c2baca394c0587b7d37ee4590091,
title = "Diet-derived phytochemicals: From cancer chemoprevention to cardio-oncological prevention",
abstract = "Cardiovascular diseases and cancer are the leading causes of death in most countries. These diseases share many common risk factors as well as pathogenetic determinants, and their incidence is related to age in an exponential manner. Furthermore, it has become apparent that several treatments used in therapy or even in prevention of cancer can impair the structural and functional integrity of the cardiovascular system, giving rise to an interdisciplinary field: cardiooncology. However, tumors and cardiovascular diseases also share common protective factors: they can be prevented either by avoiding exposure to recognized risk factors, and/or by favoring the intake of protective compounds and by modulating the host defense machinery. These latter approaches are generally known as chemoprevention. A great variety of dietary and pharmacological agents have been shown to be potentially capable of preventing cancer in preclinical models, most of which are of plant origin. Phytochemicals, in particular diet-derived compounds, have therefore been proposed and applied in clinical trials as cancer chemopreventive agents. There is now increasing evidence that some phytochemicals can be also protective for the heart, having the potential to reduce cancer, cardiovascular disease and even anticancer drug-induced cardiotoxicity. We introduce the concept that these compounds induce pre-conditioning, a low level cellular stress that induces strong protective mechanisms conferring resistance to toxins such as cancer chemotherapeutics. Cancer cells and cardiomyocytes have fundamental differences in their metabolism and sensitivity to preconditioning, autophagy and apoptosis, so that dosage of the prevention compounds is important. Here we discuss the mechanisms responsible for the cardiotoxicity of anticancer drugs, the possibility to prevent them and provide examples of diet-derived phytochemicals and other biological substances that could be exploited for protecting the cardiovascular system according to a joint cardio-oncological preventative approach.",
keywords = "Autophagy, Cancer, Cardioncology, Cardiotoxicity, Cardiovascular diseases, Chemoprevention, Phytochemicals, Preconditioning",
author = "N. Ferrari and F. Tosetti and {De Flora}, S. and F. Donatelli and I. Sogno and Noonan, {D. M.} and A. Albini",
year = "2011",
month = "12",
doi = "10.2174/138945011798184227",
language = "English",
volume = "12",
pages = "1909--1924",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "13",

}

TY - JOUR

T1 - Diet-derived phytochemicals

T2 - From cancer chemoprevention to cardio-oncological prevention

AU - Ferrari, N.

AU - Tosetti, F.

AU - De Flora, S.

AU - Donatelli, F.

AU - Sogno, I.

AU - Noonan, D. M.

AU - Albini, A.

PY - 2011/12

Y1 - 2011/12

N2 - Cardiovascular diseases and cancer are the leading causes of death in most countries. These diseases share many common risk factors as well as pathogenetic determinants, and their incidence is related to age in an exponential manner. Furthermore, it has become apparent that several treatments used in therapy or even in prevention of cancer can impair the structural and functional integrity of the cardiovascular system, giving rise to an interdisciplinary field: cardiooncology. However, tumors and cardiovascular diseases also share common protective factors: they can be prevented either by avoiding exposure to recognized risk factors, and/or by favoring the intake of protective compounds and by modulating the host defense machinery. These latter approaches are generally known as chemoprevention. A great variety of dietary and pharmacological agents have been shown to be potentially capable of preventing cancer in preclinical models, most of which are of plant origin. Phytochemicals, in particular diet-derived compounds, have therefore been proposed and applied in clinical trials as cancer chemopreventive agents. There is now increasing evidence that some phytochemicals can be also protective for the heart, having the potential to reduce cancer, cardiovascular disease and even anticancer drug-induced cardiotoxicity. We introduce the concept that these compounds induce pre-conditioning, a low level cellular stress that induces strong protective mechanisms conferring resistance to toxins such as cancer chemotherapeutics. Cancer cells and cardiomyocytes have fundamental differences in their metabolism and sensitivity to preconditioning, autophagy and apoptosis, so that dosage of the prevention compounds is important. Here we discuss the mechanisms responsible for the cardiotoxicity of anticancer drugs, the possibility to prevent them and provide examples of diet-derived phytochemicals and other biological substances that could be exploited for protecting the cardiovascular system according to a joint cardio-oncological preventative approach.

AB - Cardiovascular diseases and cancer are the leading causes of death in most countries. These diseases share many common risk factors as well as pathogenetic determinants, and their incidence is related to age in an exponential manner. Furthermore, it has become apparent that several treatments used in therapy or even in prevention of cancer can impair the structural and functional integrity of the cardiovascular system, giving rise to an interdisciplinary field: cardiooncology. However, tumors and cardiovascular diseases also share common protective factors: they can be prevented either by avoiding exposure to recognized risk factors, and/or by favoring the intake of protective compounds and by modulating the host defense machinery. These latter approaches are generally known as chemoprevention. A great variety of dietary and pharmacological agents have been shown to be potentially capable of preventing cancer in preclinical models, most of which are of plant origin. Phytochemicals, in particular diet-derived compounds, have therefore been proposed and applied in clinical trials as cancer chemopreventive agents. There is now increasing evidence that some phytochemicals can be also protective for the heart, having the potential to reduce cancer, cardiovascular disease and even anticancer drug-induced cardiotoxicity. We introduce the concept that these compounds induce pre-conditioning, a low level cellular stress that induces strong protective mechanisms conferring resistance to toxins such as cancer chemotherapeutics. Cancer cells and cardiomyocytes have fundamental differences in their metabolism and sensitivity to preconditioning, autophagy and apoptosis, so that dosage of the prevention compounds is important. Here we discuss the mechanisms responsible for the cardiotoxicity of anticancer drugs, the possibility to prevent them and provide examples of diet-derived phytochemicals and other biological substances that could be exploited for protecting the cardiovascular system according to a joint cardio-oncological preventative approach.

KW - Autophagy

KW - Cancer

KW - Cardioncology

KW - Cardiotoxicity

KW - Cardiovascular diseases

KW - Chemoprevention

KW - Phytochemicals

KW - Preconditioning

UR - http://www.scopus.com/inward/record.url?scp=80053126049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053126049&partnerID=8YFLogxK

U2 - 10.2174/138945011798184227

DO - 10.2174/138945011798184227

M3 - Article

C2 - 21158708

AN - SCOPUS:80053126049

VL - 12

SP - 1909

EP - 1924

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 13

ER -